IGAVN

Clinical trials for IGAVN explained in plain language.

Never miss a new study

Get alerted when new IGAVN trials appear

Sign up with your email to follow new studies for IGAVN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for kids with kidney disease: drug trial targets protein leak

Disease control Recruiting now

This study tests a drug called ravulizumab in children aged 2 to 18 with a kidney disease called IgA nephropathy. The goal is to see if the drug can reduce protein in the urine, which is a sign of kidney damage. Participants receive the drug through an IV and are monitored for sa…

Matched conditions: IGAVN

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated May 11, 2026 20:39 UTC

IGAVN

Get alerted when new IGAVN trials appear

New hope for kids with kidney disease: drug trial targets protein leak